861. [Percutaneous MR-guided prostate cancer cryoablation: Predictive factors and oncologic outcomes].
作者: M Gaullier.;T Tricard.;J Garnon.;R-L Cazzato.;P Munier.;P De Marini.;P Werle.;V Lindner.;A Gangi.;H Lang.
来源: Prog Urol. 2020年30卷1期12-18页
To determine the pejorative predictive factors on oncologic outcomes of percutaneous MR-guided whole gland prostate cancer cryoablation (CA).
862. [Acinic cell carcinoma: an unsuspected malignancy of the nasal cavity].
作者: Hussein Nassereddine.;Jean-Pierre Cristofari.;Caroline Halimi.;Anne Couvelard.;Alice Guyard.;Muriel Hourseau.
来源: Ann Pathol. 2020年40卷1期24-27页
Acinic cell carcinoma (ACC) is a low grade malignant tumor of the salivary glands. Primary ACC affects most frequently the parotid gland and can rarely arise in the minor salivary glands of the oral cavity, pharynx and larynx. It is extremely rare in the nasal cavity; to our knowledge only 18 cases of primary ACC of the nasal cavity are reported in the English-written literature. Herein we report a case of acinic cell carcinoma of the nasal cavity, describe the clinical, radiological and microscopic features of this uncommon presentation and finally provide a discussion in the light of relevant literature.
864. [Inverted papilloma: a study of 13 cases in the Oto-Rhino-Laryngology at the National University Hospital of Fann].
作者: Moustapha Ndiaye.;Ciré Ndiaye.;Mame Sanou Diouf.;Ndèye Oumy Sarr.;Abdou Sy.;Malick Ndiaye.;Abdourahmane Tall.
来源: Pan Afr Med J. 2019年34卷71页
Inverted Papilloma (IP) is a rare benign tumour of the nose and paranasal sinuses histologically characterized by invagination of the outer layer of the epithelium in the underlying chorion. Its most distinctive feature is a strong local aggressiveness, a tendency to recur and an unpredictable risk of association with epidermoid carcinoma. The purpose of this study was to report the epidemiological, clinical, paraclinical data as well as to assess the outcomes of endoscopic endonasal surgery.
865. [Diagnostic and therapeutic features of invasive lobular carcinoma of the breast: a study of 30 cases].
作者: Bergaoui Haïfa.;Houda El Mhabrech.;Inès Zouari.;Manel Njima.;Amira Daldoul.;Hajji Ahmed.;Hajjaji Awatef.;Wiem Khchine.;Sonia Zaidi.;Raja Faleh.
来源: Pan Afr Med J. 2019年34卷70页
Invasive lobular carcinoma (ILC) of the breast accounts for 5-15% of breast cancers. It is classified as the second most frequent histological type after non-specific invasive cancer (NSIC) and its prevalence has seen a marked increase. Clinical and radiological diagnosis is difficult. Usually, this cancer develops bilaterally and more slowly than non-specific invasive cancer, with best prognostic factors. The purpose of our study was to describe in detail the clinical, radiological, therapeutic and prognostic features of invasive lobular carcinoma. We conducted a retrospective descriptive study of 30 cases with ILC of the breast whose data were collected at the Center of Maternity and Neonatology, Monastir over a period of 10 years. The prevalence of ILC was 5.2%. The average age of patients was 53.43 years. Ten percent of patients had a personal history of benign mastopathies, 6.66% had a personal history of breast cancer and 3.33% had a family history of breast cancer. Late-stage diagnosis was made in 18 cases. Bifocal mass was found in 5 patients, multifocal mass in 4 patients and bilateral mass in 3 patients. Only one patient had liver metastasis at the time of diagnosis. Radical mastectomy (Patey) was immediately performed in 63.33% of patients. Anatomo-pathological examination showed multifocal lesions in 44.80% of cases. Lymph node dissection was satisfactory in 21 patients; 28 patients (93.33%) underwent radiotherapy and adjuvant hormonal therapy. Five-year overall survival was 77.3%.
866. [Is sarcopenia a morbi-mortality factor in the treatment of localized muscle-invasive bladder cancer?].
作者: G Fraisse.;Y Renard.;C Lebacle.;A Masson-Lecomte.;F Desgrandchamps.;C Hennequin.;T Bessede.;J Irani.
来源: Prog Urol. 2020年30卷1期41-50页
Sarcopenia evaluated from the measurement of skeletal muscle index (SMI) has been evaluated as a predictive factor of morbidity and mortality after surgery. The objective of this study was to evaluate whether it was predictive of morbidity and mortality in patients managed by cystectomy or tri-modality therapy (TMT), combining radiotherapy and chemotherapy after endoscopic resection of the tumour, for localized muscle-invasive bladder cancer.
868. [Melanoma within tattoos: Two cases and a systematic literature review].
作者: F Cherkaoui El Baraka.;N Kluger.;I Ollivier.;R Bourgoin.;M Grossin.;C Zeboulon.;C Phan.;C Sin.;E Mahé.
来源: Ann Dermatol Venereol. 2020年147卷4期285-292页
There have been reports of malignant melanoma arising within tattoos. However, there is no clear relationship between tattoos and the development of cutaneous malignancies. We report two new cases of melanoma and provide a review of cases of melanoma reported in the medical literature.
869. [Desmoid tumors: Are there still any surgical indications?].
After an adapted imaging, the diagnosis of a desmoid tumor (DT) is provided by a percutaneous microbiopsy, with a molecular analysis for beta-catenin or APC gene mutation. The therapeutic strategy must be decided in a specialized multidisciplinary tumor board (MTB). Surgery is no longer the first-line treatment for a DT. Except within a surgical complication, active surveillance is offered to the majority of patients, since more than half stabilize or regress after an initial progression, whether the location is peripheral or intra-abdominal. If the localization and/or volume are likely to be functional or life-threatening, medical induction therapy is discussed in MTB, before a local treatment whose potential sequelae would be definitive. Incomplete unplanned resection, recurrence, pregnancy or desmoids occurring in a polyposis context are no longer routine surgical indications. In an emergency setting (occlusion, peritonitis), it is discussed to treat only the mechanical complication and leave the DT in place, if its resection would lead to too much digestive resection, especially in patients who have already undergone colectomy for polyposis. The best indications for surgery are patients who have parietal locations with significant and documented progression, because surgery can be easily completed at the cost of an acceptable morbidity. In localizations where surgery would cause sequelae, medical treatment or other regional loco treatments are discussed in MTB.
870. [Off-label use of vincristine for intralesional treatment of isolated papules in Kaposi's sarcoma: Dermatologic experience with 10 patients].
作者: T Peduto.;G Fabbrocini.;M Delfino.;P Nappa.;M Guarino.;F Cillo.
来源: Ann Dermatol Venereol. 2020年147卷2期140-143页 871. [Atypical Sézary syndrome in a young subject].
作者: S Jabran-Maanaoui.;P Chauvet.;M Gillard.;B Carpentier.;L Pascal.;J-F Quinchon.;P Modiano.
来源: Ann Dermatol Venereol. 2020年147卷5期355-360页
Sézary syndrome accounts for 5% of cutaneous T-cell lymphomas, with mean age of onset of 60 years. Erythroderma associated with palmoplantar keratoderma and lymphadenopathy is the usual clinical presentation, but the disease has potentially confusing polymorphic clinical features.
872. [Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients].
作者: T Marquette.;J Walz.;S Rybikowski.;T Maubon.;N Branger.;S Fakhfakh.;K L Verde.;S Dermeche.;G Gravis.;G Pignot.
来源: Prog Urol. 2020年30卷1期35-40页
There is increasing evidence that Hyperthermic Intravesical Chemotherapy is an effective treatment for non-muscle invasive bladder cancer (NMIBC). HIVEC (COMBAT BRS system) is an innovative hyperthermia delivering device. The aim of our study is to evaluate tolerance and safety of HIVEC in patients with BCG-refractory NMIBC.
876. [Cisplatin-based chemotherapy in muscle-invasive bladder cancer: soon outdated ?].
For more than 30 years, cisplatin-based neoadjuvant chemotherapy (NAC) has been administered to patients with muscle-invasive bladder cancer (MIBC). However, the benefit is modest. With the advent of modern immunotherapies, new therapeutic strategies are also opening up to bladder cancer. Unfortunately, the initial results in the neoadjuvant context show a response rate of only 20-35 %. Other therapeutic strategies, such as Pan-FGFR inhibitors, do not show better response. Due to the high genetic variability of bladder cancer, a « one drug fits all » concept is not an ideal solution. Patient selection based on the probability of response appears to be a promising strategy to improve this modest benefit of each treatment. In this context, the NAC will also continue to play an important role.
877. [Specificity of the management of metastatic renal cancer in the older patient].
作者: Y Neuzillet.;G Albrand.;P Caillet.;E Paillaud.;P Mongiat-Artus.
来源: Prog Urol. 2019年29卷14期874-895页
To define the necessary arrangements of medical treatment with anti-angiogenics, mTOR inhibitor or systemic immunotherapies in the management of metastatic renal cell carcinoma in elderly patients.
878. [Descriptive dermoscopic study of a series of 100 patients with basal cell carcinoma diagnosed in Morocco].
作者: Meryem Soughi.;Mariam Meziane.;Salim Gallouj.;Fatimazahra Mernissi.
来源: Pan Afr Med J. 2019年34卷64页
Dermatoscopy is an innovative non-invasive technique for clinical morphology of pigmented lesions and skin tumor. The purpose of our study was to highlight the morphological and dermoscopic features of basal cell carcinoma (CBC) in our study population.
879. [Neuroendocrine tumors of the cervix: case study and literature review].
作者: Kaoutar Rais.;Ebo Egyir.;Obeid Rockson.;Abdelbassir Ramdani.;Badr Serji.;Tijani El Harroudi.
来源: Pan Afr Med J. 2019年34卷48页
Neuroendocrine tumors of the cervix are rare accounting for only 0.9-1.5% of these tumors. The non-specificity of the clinical signs and the absence of a screening test delay diagnosis. Immunohistochemical and histological studies play a crucial role to confirm the diagnosis. Today, therapeutic management is difficult and prognosis is unfavorable. We report a case of neuroendocrine tumor of the cervix and we will outline the peculiarities of this rare disease.
880. [A case study of bilateral cystic basal cell carcinoma in an albino].
作者: Manix Ilunga Banza.;Israël Badypwyla Tshiamala.;Nathalie Dinganga Kapessa.
来源: Pan Afr Med J. 2019年34卷43页
Basal cell carcinoma is the most common skin cancer. It occurs in young adults older than 50 years and it is often caused by chronic exposure to solar rays, which explains why it often affects the face. In patient who are not treated immediately, the tumour develops slowly, with locoregional extension, but it rarely metastasizes. We here report a very rare case of bilateral cystic basal cell carcinoma in an albino young adult aged 36 years. The patient had terebrant left brachial ulcero-budding infiltrating mass with bone erosion (pathological fracture of the humerus) evolving over the last 7 years as well as ulcero-budding secondarily infected mass in the cervicodorsal junction evolving over the last 6 months. During his 1 month stay in our hospital, he underwent transfusion of 6 units of isogroup isoRh 450cc and boric acid dressings were applied as a complement to antibiotic therapy and iron therapy. Given the poor general health of the patient (cachexia, chronic anemia, development of the cancerous lesions), amputation of the left upper member and cervicodorsal mass excision were controindicated. Multidisciplinary team opted for second line treatment, including chemotherapy and/or radiotherapy. Given the lack technical equipment, the patient was transferred out to Lusaka.
|